Gunma, Japan

Yasumasa Yoshie

This inventor holds 1 USPTO granted patent. Top assignee: Daiichi Seiyaku Co., Ltd.. Active years: 1989.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yasumasa Yoshie. Retrieved from https://idiyas.com/inventor/yasumasa-yoshie

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 1989

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yasumasa Yoshie: Innovator in Antiasthmatic Treatments

Introduction

Yasumasa Yoshie is a notable inventor based in Gunma, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for asthma. His innovative approach has led to the creation of a unique antiasthmatic agent.

Latest Patents

Yasumasa Yoshie holds a patent for an antiasthmatic agent. This agent is designed for the treatment and prevention of asthma and comprises 2-[2-phenyl-2-(2-pyridyl)]ethyl-2-imidazoline or a salt thereof as an active ingredient. This patent highlights his commitment to improving respiratory health.

Career Highlights

Yasumasa Yoshie is associated with Daiichi Seiyaku Co., Ltd., a company known for its dedication to pharmaceutical innovation. His work at the company has been instrumental in advancing treatments for respiratory conditions. With 1 patent to his name, he has established himself as a key figure in the pharmaceutical industry.

Collaborations

Throughout his career, Yasumasa Yoshie has collaborated with esteemed colleagues, including Setsuo Kobayashi and Tsugio Nakazawa. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Yasumasa Yoshie's contributions to the field of antiasthmatic treatments exemplify his dedication to improving patient outcomes. His innovative spirit and collaborative efforts continue to influence the pharmaceutical landscape.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…